8-K:重大事件
04/25 16:38 (美東)
8-K:重大事件
04/17 16:37 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | DEFA14A:其他
03/27 17:05 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 10-K:年度報表
03/25 08:03 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | DEF 14A:股東委託書決議
03/19 17:29 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | PRE 14A:並購重組委托聲明
03/08 17:02 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 8-K:重大事件
03/08 17:02 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 8-K:重大事件
03/01 16:36 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Ionic Ventures, LLC(4.0%),Ionic Management, LLC(4.0%)等
02/14 18:13 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | S-8:員工福利計劃證券登記
02/14 16:43 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-Anson Funds Management LP(9.8%),Anson Management GP LLC(9.8%)等
02/14 16:21 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-L1 Capital Global Opportunities Master Fund Ltd.(0%)
02/09 16:06 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-INCON Co., Ltd.(3.44%)
01/19 00:00 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 8-K:重大事件
2023/12/22 16:45 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 8-K:重大事件
2023/12/11 16:30 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 424B4:募資說明書
2023/12/08 16:44 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | EFFECT:其他
2023/12/07 00:15 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | S-1/A:證券上市註冊聲明(修正)
2023/12/06 16:13 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | CORRESP:信函
2023/12/06 00:00 (美東)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | CORRESP:信函
2023/12/06 00:00 (美東)
暫無數據
暫無數據